NOP2 ‐Mediated m5C Methylation Modification of LMNB2 mRNA Facilitates Colorectal Cancer Progression
Cancer Medicine · 2025-05 · 14 (10)
DOI: 10.1002/cam4.70970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 14.05.2025. Verfasst von Jinling Bi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second People's Hospital of Hefei, Hefei, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, RNA, Messenger, 5-Methylcytosine, Methyltransferases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Project of State Key Laboratory of Radiation Medicine and Protection, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) is a leading cause of cancer‐related mortality globally, yet current therapies exhibit suboptimal efficacy with limited prognostic improvement. RNA 5‐methylcytosine (m5C), a posttranscriptional modification, has been implicated in tumorigenesis and progression across malignancies. In our previous study, the m5C methyltransferase NOP2 has been shown to promote proliferation, migration, and invasion of CRC cells, however, the underlying mechanism is still elusive.
Methods
An integrated multi‐omics strategy was employed, combining transcriptomic sequencing, RNA immunoprecipitation sequencing (RIP‐seq), and methylated RNA immunoprecipitation sequencing (MeRIP‐seq) to explore NOP2‐regulated downstream genes mediating CRC progression via m5C methylation. Functional validation included in vitro and in vivo assays to assess tumor growth and metastasis. Rescue experiments were performed by overexpressing LMNB2 in NOP2‐silenced CRC cells.
Results
NOP2‐dependent m5C modification of LMNB2 mRNA enhanced its stability, leading to elevated LMNB2 protein levels. This mechanism drove CRC tumor growth and metastasis both in vitro and in vivo. Overexpression of LMNB2 effectively rescued the suppressed malignant phenotypes induced by NOP2 knockdown, confirming LMNB2 as a critical downstream effector.
Conclusion
NOP2 catalyzes the m5C modification of LMNB2 mRNA to facilitate its stability, which contributes to the elevated LMNB2 protein level and CRC progression, suggesting the potential of NOP2 as a therapeutic target in the development of novel CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second People's Hospital of Hefei, Hefei, China.
- Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow Universi…
ORCID-Profile: Wentao Hu, Yulong Liu
Förderung
- Open Project of State Key Laboratory of Radiation Medicine and Protection
- National Natural Science Foundation of China
Zitieren
APA
Bi, J., Huang, Y., Hu, W., & Liu, Y. (2025). NOP2 ‐Mediated m5C Methylation Modification of LMNB2 mRNA Facilitates Colorectal Cancer Progression. Cancer Medicine, 14(10). https://doi.org/10.1002/cam4.70970
Vancouver
Bi J, Huang Y, Hu W, Liu Y. NOP2 ‐Mediated m5C Methylation Modification of LMNB2 mRNA Facilitates Colorectal Cancer Progression. Cancer Medicine. 2025;14(10). doi:10.1002/cam4.70970
BibTeX
@article{Bi2025,
author = {Bi, Jinling and Huang, Yong and Hu, Wentao and Liu, Yulong},
title = {NOP2 ‐Mediated m5C Methylation Modification of LMNB2 mRNA Facilitates Colorectal Cancer Progression},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {10},
doi = {10.1002/cam4.70970}
}
EUVIMED